Research output per year
Research output per year
- 11 results
Search results
-
2018
Thinking about the nerve impulse: A critical analysis of the electricity-centered conception of nerve excitability
Drukarch, B., Holland, H. A., Velichkov, M., Geurts, J. J. G., Voorn, P., Glas, G. & de Regt, H. W., Oct 2018, In: Progress in Neurobiology. 169, p. 172-185 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access44 Citations (Scopus) -
2017
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Chrobok, N. L., Sestito, C., Wilhelmus, M. M. M., Drukarch, B. & van Dam, A. M., 1 Mar 2017, In: Amino acids. 49, 3, p. 441-452 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
23 Citations (Scopus) -
2015
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J., van der Valk, P., Drukarch, B. & van Dam, A-M., Sept 2015, In: Annals of the New York Academy of Sciences. 1351, p. 99-113 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
54 Citations (Scopus) -
2008
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases
Wilhelmus, M. M. M., van Dam, A-M. & Drukarch, B., 13 May 2008, In: European journal of pharmacology. 585, 2-3, p. 464-472 9 p.Research output: Contribution to journal › Review article › Academic › peer-review
53 Citations (Scopus) -
2007
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology
Konsman, J. P., Drukarch, B. & Van Dam, A-M., Jan 2007, In: Clinical science. 112, 1, p. 1-25 25 p.Research output: Contribution to journal › Review article › Academic › peer-review
138 Citations (Scopus) -
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology
Schreibelt, G., van Horssen, J., van Rossum, S., Dijkstra, C. D., Drukarch, B. & de Vries, H. E., Dec 2007, In: Brain Research. 56, 2, p. 322-30 9 p.Research output: Contribution to journal › Review article › Academic › peer-review
146 Citations (Scopus) -
2001
Neuroprotection for Parkinson's disease: a new approach for a new millennium
Drukarch, B. & van Muiswinkel, F. L., Oct 2001, In: Expert opinion on investigational drugs. 10, 10, p. 1855-68 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
31 Citations (Scopus) -
1999
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy
Stoof, J. C., Winogrodzka, A., van Muiswinkel, F. L., Wolters, E. C., Voorn, P., Groenewegen, H. J., Booij, J. & Drukarch, B., 30 Jun 1999, In: European journal of pharmacology. 375, 1-3, p. 75-86 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
39 Citations (Scopus) -
1992
In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor
Stoof, J. C., Drukarch, B., de Boer, P. & Westerink, B. H., Mar 1992, In: Neurochemistry International. 20 Suppl, p. 201S-205SResearch output: Contribution to journal › Review article › Academic › peer-review
8 Citations (Scopus) -
Regulation of the activity of striatal cholinergic neurons by dopamine
Stoof, J. C., Drukarch, B., de Boer, P., Westerink, B. H. & Groenewegen, H. J., 1992, In: Neuroscience. 47, 4, p. 755-70 16 p.Research output: Contribution to journal › Review article › Academic › peer-review
165 Citations (Scopus) -
1990
D-2 dopamine autoreceptor selective drugs: do they really exist?
Drukarch, B. & Stoof, J. C., 1990, In: Life sciences. 47, 5, p. 361-76 16 p.Research output: Contribution to journal › Review article › Academic › peer-review
61 Citations (Scopus)